BG Medicine, Inc. (BGMD) Reports In-Line Q1 Loss of 8c/Share

BG Medicine, Inc. (NASDAQ: BGMD) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $739 thousand versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on BG Medicine, Inc. (BGMD) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• Arena Group to rename as Paradium.AI, ticker changing to PAAI